Introduction
The major histocompatibility complex (MHC) in humans consists of several loci of genes located on the short arm of chromosome 6 at 6p21.3. These loci are classified into Class I, II, and III of the MHC and the genes of human leukocyte antigen (HLA) alleles are situated in the MHC Class I and II regions. The HLA genes are characterized by their extreme allelic polymorphism and their variations and diversity among different ethnic groups and racial populations. As the HLA molecule similarity between donors and recipients is being used as a prediction factor for graft survival and graft-versus-host disease, it is imperative to characterize precisely any new allele encountered during routine HLA typing procedures. To facilitate successful and comprehensive unrelated bone marrow donor searches for patients in need of hematopoietic stem cell transplantation, we are persistently working on resolving Conflicts of interest: none. * Corresponding author. Buddhist Tzu Chi Stem Cells Center, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan. Tel.: þ886 38561825x3373; fax: þ886 38567851.
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Tzu Chi Medical Journal j o u r n a l h o me p a g e : w w w . t z u c h i m e d j n l . c o m ambiguous or unidentified alleles that we find to offer better services for HLA matching and donor selection. HLA-A*31:30 and HLA-B*40:55 were first reported to the immunogenetics (IMGT)/HLA database in 2010 and 2004, respectively [1] , without an indication of probable HLA-associated haplotypes. Here we report the deduced probable HLA haplotypes in association with A*31:30 and B*40:55. We further postulate that the deduced plausible HLA haplotype in association with A*31:30 is most likely conserved in the Taiwanese population, based on its low frequency in the general population and the fact that it has so far been reported only in a Taiwanese population [1] . Similarly, the deduced probable B*40:55-associated HLA haplotype A*02:07-B*40:55-DRB1*04:05 is most likely conserved in the Taiwanese population, whereas the other deduced probable B*40:55-associated haplotype, A*26:01-B*40:55-DRB1*09:01, is conserved in Japanese and Taiwanese populations.
Materials and methods
Peripheral whole blood samples from three unrelated bone marrow stem cell donors with Taiwanese ethnicity were collected in acid citrate dextrose (ACD) anticoagulant. Formal written consents were signed by the donors before blood collection. The ACD whole blood was stored at e80 C until use. Genomic DNA was extracted using the QIAamp DNA Blood Mini Kit according to the manufacturer's instructions (Qiagen, Hilden, Germany). Genomic DNA typing of HLA-A, -B, and -DRB1 loci was first performed using Dynal Reli-sequence-specific oligonucleotide probe (SSO) HLA-A, -B, and -DRB1 Typing Kits (Dynal Biotech, Bromborough, Wirral, UK), followed by the sequence-specific primer (SSP) typing method (AllSet Gold SSP HLA high-resolution kits; Dynal Biotech, Invitrogen, Brown Deer, WI, USA) to reach high-resolution allelic subtypes. The sequence-based typing method [2e6] was used to confirm the low-incidence alleles observed, and in cases of anomalous results and typing ambiguities from the SSO and SSP typing protocols. Polymerase chain reaction was carried out to amplify exons 2, 3, and 4 of the HLA-C locus and exon 2 of the DQB1 locus with group-specific primer sets as previously described [7] . Amplicons were sequenced by the BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Foster City, CA, USA) in both directions. In this study, A*31:30 from one blood donor and B*40:55 from another two blood donors were sequenced and analyzed.
Results
We confirmed that the DNA sequence of A*31:30 is identical to A*31:01:02 in exons 2, 3, and 4, except for a nucleotide substitution at residue 539 (T/G) [1] (Fig. 1 cDNA  80  90  100  110  120  130  140  150  160  170  A*31:01:02  GCTCCCA CTCCATGAGG TATTTCACCA CATCCGTGTC CCGGCCCGGC CGCGGGGAGC CCCGCTTCAT CGCCGTGGGC TACGTGGACG ACACGCAGTT  A*31:30 - cDNA  180  190  200  210  220  230  240  250  260  270  A*31:01:02  CGTGCGGTTC GACAGCGACG CCGCGAGCCA GAGGATGGAG CCGCGGGCGC CGTGGATAGA GCAGGAGAGG CCTGAGTATT GGGACCAGGA GACACGGAAT  A*31:30 - cDNA  280  290  300  310  320  330  340  350  360  370  A*31:01:02 GTGAAGGCCC ACTCACAGAT TGACCGAGTG GACCTGGGGA CCCTGCGCGG CTACTACAAC CAGAGCGAGG CCG|GTTCTCA CACCATCCAG ATGATGTATG A*31:30
GCTGCGACGT GGGGTCGGAC GGGCGCTTCC TCCGCGGGTA CCAGCAGGAC GCCTACGACG GCAAGGATTA CATCGCCTTG AACGAGGACC TGCGCTCTTG A*31:30 
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Discussion
In this study we confirmed the DNA sequence of two lowfrequency HLA alleles, A It is worth mentioning that the classical and most direct method of determining HLA haplotype is through family study if test materials from a number of key family members are available. Alternatively, population study may be used if a sufficient number of unrelated donors are available [7] . However, the haplotypes deduced through population investigation are only considered likely or most probable. In this study, because of the availability of the necessary test materials, we opted to determine the haplotypes by looking at the HLA alleles carried in common by unrelated donors with the same alleles of interest. By the same token, if determination of plausible HLA haplotypes is for rare HLA alleles, alleles shared in common by unrelated individuals may be used to deduce the probable associated haplotypes [7e16]. The frequencies of A*31:30 and B*40:55 in the Taiwanese population are extremely low at about 1 in 20,000 to 1 in 30,000 according to our HLA typing practice. Therefore, we think the probable HLA-A*31:30 and HLA-B*40:55-associated haplotypes that we postulated in this study are highly reliable.
The HLA alleles are increasing exponentially with the recent development of DNA-based molecular typing technology. By contrast, HLA diversity in every ethnic group is unique and important. Finding appropriate HLA-matched unrelated bone marrow stem cell donors for a given needy patient for successful stem cell transplantations relies on the accuracy of HLA typing   cDNA  80  90  100  110  120  130  140  150  160  170  B*40:01:01  GCTCCCA CTCCATGAGG TATTTCCACA CCGCCATGTC CCGGCCCGGC CGCGGGGAGC CCCGCTTCAT CACCGTGGGC TACGTGGACG ACACGCTGTT  B*40:55 - cDNA  180  190  200  210  220  230  240  250  260  270  B*40:01:01  CGTGAGGTTC GACAGCGACG CCACGAGTCC GAGGAAGGAG CCGCGGGCGC CATGGATAGA GCAGGAGGGG CCGGAGTATT GGGACCGGGA GACACAGATC  B*40:55 - cDNA  380  390  400  410  420  430  440  450  460  470  B*40:01:01 GCTGCGACGT GGGGCCGGAC GGGCGCCTCC TCCGCGGGCA TAACCAGTAC GCCTACGACG GCAAGGATTA CATCGCCCTG AACGAGGACC TGCGCTCCTG B*40:55 results and the spirit and strength to resolve unknown, discrepant, and ambiguous genes in the HLA system.
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